Intellectual Property India Publishes Patent Application for 'Crystalline Forms Of 5-[(2,4-Dinitrophenoxy)Methyl]-1-Methyl-2-Nitro-1h-Imidazole' Filed by Rivus Pharmaceuticals, Inc.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051877 A) filed by Rivus Pharmaceuticals, Inc., Charlottesville, U.S.A., on May 29, for 'crystalline forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1h-imidazole.'

Inventor(s) include Duvvuri, Muralikrishna; Lamunyon, Donald Herbert; and Bodner, Micah Jeffrey.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to polymorphic forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole for treating mitochondria-related disorders or conditions."

The patent application was internationally filed o...